These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17309552)

  • 1. Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography.
    Yapp DT; Woo J; Kartono A; Sy J; Oliver T; Skov KA; Koch CJ; Adomat H; Dragowska WH; Fazli L; Ruth T; Adam MJ; Green D; Gleave M
    BJU Int; 2007 May; 99(5):1154-60. PubMed ID: 17309552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using (19)F magnetic resonance spectroscopy.
    Hoff MN; Yapp DT; Yung AC; Oliver TS; Kozlowski P
    Int J Radiat Biol; 2008 Mar; 84(3):237-42. PubMed ID: 18300024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages.
    Skov K; Adomat H; Bowden M; Dragowska W; Gleave M; Koch CJ; Woo J; Yapp DT
    Radiat Res; 2004 Nov; 162(5):547-53. PubMed ID: 15624309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Tumor Hypoxia With 18F-EF5 PET/MRI in Cervical Cancer.
    Narva SI; Seppänen MP; Raiko JRH; Forsback SJ; Orte KJ; Virtanen JM; Hynninen J; Hietanen S
    Clin Nucl Med; 2021 Dec; 46(12):952-957. PubMed ID: 34619699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial tumour blood-flow measurements in androgen-dependent and -independent Shionogi tumour models.
    Kozlowski P; Wong J; Goldenberg SL
    BJU Int; 2005 Mar; 95(4):644-9. PubMed ID: 15705096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography.
    Lawrentschuk N; Poon AM; Foo SS; Putra LG; Murone C; Davis ID; Bolton DM; Scott AM
    BJU Int; 2005 Sep; 96(4):540-6. PubMed ID: 16104907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
    Komar G; Seppänen M; Eskola O; Lindholm P; Grönroos TJ; Forsback S; Sipilä H; Evans SM; Solin O; Minn H
    J Nucl Med; 2008 Dec; 49(12):1944-51. PubMed ID: 18997048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake.
    Koch CJ; Shuman AL; Jenkins WT; Kachur AV; Karp JS; Freifelder R; Dolbier WR; Evans SM
    Int J Radiat Biol; 2009 Dec; 85(12):1137-47. PubMed ID: 19995239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.
    Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1011-5. PubMed ID: 21372297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer.
    Wright P; Arnesen MR; Lønne PI; Suilamo S; Silvoniemi A; Dale E; Minn H; Malinen E
    Acta Oncol; 2021 Nov; 60(11):1386-1391. PubMed ID: 34184605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?
    Busk M; Horsman MR; Jakobsen S; Hansen KV; Bussink J; van der Kogel A; Overgaard J
    Radiother Oncol; 2009 Sep; 92(3):429-36. PubMed ID: 19729214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
    Oyama N; Kim J; Jones LA; Mercer NM; Engelbach JA; Sharp TL; Welch MJ
    Nucl Med Biol; 2002 Nov; 29(8):783-90. PubMed ID: 12453586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.
    Chitneni SK; Bida GT; Yuan H; Palmer GM; Hay MP; Melcher T; Wilson WR; Zalutsky MR; Dewhirst MW
    J Nucl Med; 2013 Aug; 54(8):1339-46. PubMed ID: 23740105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.
    Ziemer LS; Evans SM; Kachur AV; Shuman AL; Cardi CA; Jenkins WT; Karp JS; Alavi A; Dolbier WR; Koch CJ
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):259-66. PubMed ID: 12552344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure.
    Dolbier WR; Li AR; Koch CJ; Shiue CY; Kachur AV
    Appl Radiat Isot; 2001 Jan; 54(1):73-80. PubMed ID: 11144255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models.
    Ali R; Apte S; Vilalta M; Subbarayan M; Miao Z; Chin FT; Graves EE
    PLoS One; 2015; 10(10):e0139425. PubMed ID: 26431331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of
    Wadsworth BJ; Decotret LR; Villamil C; Yapp D; Wilson D; Benard F; McKenzie M; Bennewith KL
    Acta Oncol; 2021 Nov; 60(11):1489-1498. PubMed ID: 34379579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
    Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
    J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeatability of tumour hypoxia imaging using [
    Silvoniemi A; Suilamo S; Laitinen T; Forsback S; Löyttyniemi E; Vaittinen S; Saunavaara V; Solin O; Grönroos TJ; Minn H
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):161-169. PubMed ID: 29075831
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Qian Y; Von Eyben R; Liu Y; Chin FT; Miao Z; Apte S; Carter JN; Binkley MS; Pollom EL; Harris JP; Prionas ND; Kissel M; Simmons A; Diehn M; Shultz DB; Brown JM; Maxim PG; Koong AC; Graves EE; Loo BW
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1183-1192. PubMed ID: 29859786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.